SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Biogen Pharmachem Industries Ltd

BSE: 531752 NSE: ISIN: INE703D01023
  |   Sector:  Miscellaneous   |   Industry:  Trading

Snapshot

Q.1 Which industry/sub-sector does Biogen Pharmachem Industries Ltd belong to?
Biogen Pharmachem Industries Ltd belongs to the Miscellaneous sector, operating specifically within the Trading segment.
Q.2 Is Biogen Pharmachem Industries Ltd a good quality company?
Biogen Pharmachem Industries Ltd is a quality company, based on a 10 year financial track record.
Q.3 Is Biogen Pharmachem Industries Ltd undervalued or overvalued?
Biogen Pharmachem Industries Ltd appears Fair, as its key valuation ratios are in line with their past averages.
Q.4 Is Biogen Pharmachem Industries Ltd a good buy now?
Biogen Pharmachem Industries Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Biogen Pharmachem Industries Ltd?
Biogen Pharmachem Industries Ltd revenue growth is 0% for FY-2025 , which is in line with its 5 year CAGR of 0% , indicating stable growth.
Q.2 Gross Profit margin of Biogen Pharmachem Industries Ltd?
Biogen Pharmachem Industries Ltd Gross profit margin which is the profit after deduction of direct costs, is 0% for FY-2025 , which is in line with its 5 year median of 0% , indicating stable margins.
Q.3 Operating Profit Margin of Biogen Pharmachem Industries Ltd?
Biogen Pharmachem Industries Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 0% for FY-2025 , which is in line with its 5 year median of 0% indicating stable margins.
Q.4 Net Profit Margin of Biogen Pharmachem Industries Ltd?
Biogen Pharmachem Industries Ltd Net Profit Margin is -% for FY-2025 , is in line with with its 5 year median of -%, indicating stable margins.
Current Level Historic Median
Gross Profit Margin - -
Operating Profit Margin - -
Net Profit Margin - -
Q.5 Return on Asset of Biogen Pharmachem Industries Ltd?
Biogen Pharmachem Industries Ltd Return on Asset is -0.39(x), which is below its 5 year historical median of -0.02(x), indicating deteriorated asset utilization efficiency.
Q.6 Return on Equity (ROE) of Biogen Pharmachem Industries Ltd?
Biogen Pharmachem Industries Ltd Return on equity is -0.52% for FY-2025 , which is below its historical median of -0.02%, indicating the business is making worse use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Biogen Pharmachem Industries Ltd?
Biogen Pharmachem Industries Ltd Return on capital employed is -0.36% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8 Cash conversion cycle of Biogen Pharmachem Industries Ltd?
Biogen Pharmachem Industries Ltd Cash conversion cycle is 0 , in line with its historical median of 0 , indicating stable working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover - -
ROE -0.52 -0.02
ROCE -0.36 -0.02
Cash Conversion Cycle - -
Q.9 Debt to Equity ratio of Biogen Pharmachem Industries Ltd?
Biogen Pharmachem Industries Ltd Debt-to-Equity ratio is 0.00 , which is lower with the industry average of 0.03 , indicating lower debt levels in the industry.
Q.10 Debt to cash flow from operations of Biogen Pharmachem Industries Ltd?
Biogen Pharmachem Industries Ltd Debt to cash flow from operations is 0 , which is at a healthy level, indicating the business is able to service its debt comfortably.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Biogen Pharmachem Industries Ltd?
Promoters hold 0.00% of the Biogen Pharmachem Industries Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Biogen Pharmachem Industries Ltd vs industry peers?
Biogen Pharmachem Industries Ltd revenue CAGR is 0.00% , compared to the industry median CAGR of 0% , indicating stable growth and maintaining its market share.
Profit Metrics
Current Level Industry Median
Revenue - 13.3
Gross Profit - 0.4
Operating Profit -1.5 0
Net Profit -0.3 0.3
Operating Efficiency
Current Level Industry Median
Asset Turnover - 0.5
ROE -0.52 2.03
ROCE -0.36 3.6
Cash Conversion Cycle - 41

Valuation & price assessment

Q.1 Stock return of Biogen Pharmachem Industries Ltd over the last decade?
Over the last 9 years, the stock has delivered a CAGR of 10.2% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 10.2% 11.5% -11% -46.8%
Q.3 Valuation ratios of Biogen Pharmachem Industries Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 17.73 0.00 21.75
Price to Book 0.44 1.23 1.55
Price to Sales - 16.33 1.87
EV to EBITDA 17.58 -48.05 13.67

Check more companies

1. Aditya Infotech
2. Aegis Logistics
3. Redington
4. RRP Semiconductor
5. Honasa Consumer
6. Cello World
7. Lloyds Enterprises
8. MMTC
9. Jeena Sikho Life
10. SG Mart
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×